PDGFRB and neoplasm: Whereas type B cultures showed mesenchymal features and were responsive to mono-treatment with the PDGFR inhibitor imatinib, and also to IGF-1R inhibitor, NVP-AEW541, the type A cultures displayed stem cell-like features, including in vitro self-renewal and neurosphere formation, and in vivo tumor growth.